
GBS GBS
Quarterly report 2025-Q3
added 11-12-2025
Country |
|
IPO year |
2020 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
5.27 M |
Market Cap[1] |
$ 7.12 M |
EBITDA (LTM) |
$ -9.44 M |
P/E (LTM) |
- |
P/S (LTM) |
1.96 |
EPS (LTM) |
-1.99 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Alphatec Holdings
ATEC
|
$ 20.75 | -1.38 % | $ 2.97 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Apyx Medical Corporation
APYX
|
$ 3.55 | 1.51 % | $ 123 M | Nasdaq Global Select Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 9.08 | -3.4 % | $ 652 M | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 94.69 | -0.71 % | $ 139 B | NYSE,SPB | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 303.92 | 0.16 % | $ 8.57 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Bruker Corporation
BRKR
|
$ 48.19 | 2.28 % | $ 7.18 K | Nasdaq Global Select Market,SPB | ||
|
Electromed
ELMD
|
$ 28.0 | -3.85 % | $ 237 M | NYSE American | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Abbott Laboratories
ABT
|
$ 124.11 | -0.94 % | $ 216 B | NYSE,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.34 | 1.37 % | $ 125 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
IRadimed Corporation
IRMD
|
$ 97.29 | 0.01 % | $ 1.23 B | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
InMode Ltd.
INMD
|
$ 14.91 | 1.46 % | $ 1.18 B | Nasdaq Global Select Market,SPB | ||
|
LivaNova PLC
LIVN
|
$ 61.59 | 0.1 % | $ 3.34 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 11.58 | -0.43 % | $ 133 M | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 156.27 | 0.08 % | $ 11.7 B | Nasdaq Global Select Market,SPB | ||
|
Accuray Incorporated
ARAY
|
$ 0.85 | 3.12 % | $ 87.4 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 13.99 | 2.27 % | $ 378 M | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.55 | -0.08 % | $ 122 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 31.21 | -4.64 % | $ 1.38 B | Nasdaq Capital Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.13 | -0.88 % | $ 18.2 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 40.78 | 0.49 % | $ 1.26 B | NYSE,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 17.4 | -2.03 % | $ 402 M | Nasdaq Global Select Market,SPB | ||
|
Globus Medical
GMED
|
$ 86.15 | -1.33 % | $ 11.7 B | NYSE,SPB | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 12.35 | -0.56 % | $ 951 M | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Myomo
MYO
|
$ 0.97 | 6.92 % | $ 6.84 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.